Stock Track | Moderna Shares Soar 9% on Buyout Speculation

Stock Track
Oct 30, 2025

Shares of Moderna, Inc. (MRNA) are soaring in intraday trading, with the stock price surging by 9.39% as investors react to reports of potential buyout talks.

According to STAT News, Moderna is reportedly in discussions with at least one large pharmaceutical company regarding a deal of significant scope, which could include a potential buyout. This news has sparked intense interest among investors, driving the stock's dramatic rise.

The biotechnology company, known for its mRNA technology and COVID-19 vaccine, has been a subject of market speculation in recent times. While details of the potential deal remain undisclosed, the mere possibility of a buyout has been enough to trigger a substantial rally in Moderna's stock price. Investors and industry watchers will be closely monitoring further developments in this unfolding story.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10